Molecular Rapid Diagnostics Influenza/RSV/SARS-CoV-2
The Molecular Rapid Diagnostics program is designed to detect and identify Influenza A and B, RSV, and SARS-CoV-2 using rapid molecular assays. It features a reduced panel of current circulating strains and a shorter survey time to simulate real-world clinical testing using these assays.